Strong customer demand and solid operational performance in the first quarter

Strategic priorities and capital allocation approach remain unchanged

Full-year guidance ranges reaffirmed

All amounts are in US dollars, except as otherwise noted

Nutrien Ltd. (TSX and NYSE:NTR) announced today its first quarter 2026 results, with net earnings of $139 million ($0.27 diluted net earnings per share). First quarter 2026 adjusted EBITDA¹ was $1.11 billion and adjusted net earnings per share¹ was $0.51.

"Nutrien delivered record potash sales volumes and stronger Nitrogen and Retail performance in the first quarter. We increased production from our low-cost North American assets and positioned our supply chain to reliably supply our customers amid tightening global fertilizer supply and demand fundamentals," commented Ken Seitz, Nutrien's President and CEO. "We continue to take purposeful steps to simplify the business, strengthen and grow our core asset base and improve capital efficiency, resulting in a more resilient portfolio and delivering structural free cash flow growth."

Highlights²:

Retail adjusted EBITDA increased to $108 million in the first quarter of 2026 due to higher crop nutrient sales volumes and stronger proprietary products gross margins in the US and Australia. In the first quarter, we completed a tuck-in acquisition of a high-quality retail business located in the US corn belt.

Potash adjusted EBITDA increased to $578 million in the first quarter of 2026 due to higher global benchmarks and record sales volumes. We increased potash production and continued to progress mine automation, maintaining our controllable cash cost of product manufactured¹ below $60 per tonne.

Nitrogen adjusted EBITDA increased to $482 million in the first quarter of 2026 primarily due to higher global benchmarks. Our low-cost North American nitrogen plants delivered an ammonia operating rate³ of 92 percent in the first quarter of 2026, consistent with our planned production and reflective of a continued focus on reliability initiatives.

Returned $409 million to shareholders in the first quarter of 2026 through dividends and share repurchases.

Progressing as planned with the review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business with a focus on enhancing earnings quality and free cash flow.

1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section. All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.

2 Our discussion of highlights set out on this page is a comparison of the results for the three months ended March 31, 2026 to the results for the three months ended March 31, 2025, unless otherwise noted.

3 Excludes Trinidad and Joffre.

Management's Discussion and Analysis

The following management's discussion and analysis ("MD&A") is the responsibility of management and is dated as of May 6, 2026. The Board of Directors ("Board") of Nutrien carries out its responsibility for review of this disclosure principally through its Audit Committee, composed entirely of independent directors. The Audit Committee reviews and, prior to its publication, approves this disclosure pursuant to the authority delegated to it by the Board. The term "Nutrien" refers to Nutrien Ltd. and the terms "we", "us", "our", "Nutrien" and "the Company" refer to Nutrien and, as applicable, Nutrien and its direct and indirect subsidiaries on a consolidated basis. Additional information relating to Nutrien (which, except as otherwise noted, is not incorporated by reference herein), including our annual report dated February 19, 2026 ("2025 Annual Report"), which includes our annual audited consolidated financial statements ("annual financial statements") and MD&A, and our annual information form dated February 19, 2026, each for the year ended December 31, 2025, can be found on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. No update is provided to the disclosure in our 2025 annual MD&A except for material information since the date of our annual MD&A. The Company is a foreign private issuer under the rules and regulations of the US Securities and Exchange Commission (the "SEC").

This MD&A is based on, and should be read in conjunction with, the Company's unaudited interim condensed consolidated financial statements as at and for the three months ended March 31, 2026 ("interim financial statements") based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and prepared in accordance with International Accounting Standard ("IAS") 34 "Interim Financial Reporting", unless otherwise noted. This MD&A contains certain non-GAAP financial measures and ratios and forward-looking statements, which are described in the "Non-GAAP Financial Measures" and the "Forward-Looking Statements" sections, respectively.

Market Outlook and Guidance

The conflict in the Middle East and related geopolitical uncertainty has disrupted global fertilizer and energy markets, with the most direct impact on nitrogen and phosphate supply from that region, as well as associated feedstock cost and availability. The outlook below reflects current market conditions and ongoing market dynamics.

Agriculture and Retail Markets

Higher global grain and oilseed production in 2025 increased stocks-to-use ratios towards historical average levels and led to significant nutrient removal from the soil. Strong demand for food, feed and biofuel is expected to drive continued need for higher global crop production and related crop inputs. Global grain and oilseed prices have strengthened in 2026 due to robust demand and the emergence of regional weather issues that could impact prospective production.

We have maintained our US crop acreage projections with corn plantings of 94 to 96 million acres and soybean plantings of 84 to 86 million acres in 2026. We have seen healthy crop input demand over the first four months of 2026 in line with our prior expectations, supported by above average planting progress and the need to replenish soil nutrients following last year's record crop.

In Australia, favorable weather conditions across key cropping regions and strong livestock prices are supporting sales of retail products and services. In Brazil, safrinha corn planting supported crop input demand in the first quarter and growers prioritized potash purchases.

Crop Nutrient Markets

Global potash demand remains strong and we have maintained our previous forecast range for global potash shipments of 74 to 77 million tonnes in 2026. We anticipate relatively tight potash fundamentals throughout 2026 with demand trends expected to test existing global operating and supply chain capabilities.

Global nitrogen market fundamentals have tightened due to trade flow disruptions and elevated natural gas costs and LNG availability have impacted nitrogen production and costs for producers in Asia, Europe and other key regions. The outlook for the remainder of 2026 is expected to be impacted by uneven restoration of trade flows and restart of nitrogen assets, as well as uncertainty regarding Chinese urea exports and Indian urea imports.

Global phosphate supply and demand has been impacted by trade flow disruptions, lower global operating rates due to elevated feedstock costs that have pressured margins, and continued uncertainty regarding Chinese exports.

Financial and Operational Guidance

We have maintained all 2026 full year financial and operational guidance ranges.

Retail adjusted EBITDA guidance of $1.75 to $1.95 billion represents structural growth in our downstream business consistent with historical rates.

Potash sales volume guidance of 14.1 to 14.8 million tonnes is consistent with our global shipment expectation.

Nitrogen sales volume guidance of 9.2 to 9.7 million tonnes is supported by planned reliability improvements and debottlenecks.

Phosphate sales volume guidance of 2.4 to 2.6 million tonnes reflect the benefits of reliability improvement initiatives completed in 2025.

Total capital expenditures guidance of $2.0 to $2.1 billion is consistent with 2025 as we continue to optimize capital to sustain safe and reliable operations and to progress a set of targeted growth investments. The total includes approximately $400 million in investing capital expenditures focused on proprietary products, network optimization and digital capabilities in Retail, low-cost brownfield expansions and product optimization projects in Nitrogen, and mine automation in Potash.

All guidance numbers, including those noted above, are outlined in the table below. Refer to page 33 of our 2025 Annual Report for anticipated fertilizer pricing and natural gas price sensitivities relating to adjusted EBITDA (consolidated) and adjusted net earnings per share.

	2026 Guidance Ranges¹ as of
	May 6, 2026		February 18, 2026
($ billions, except as otherwise noted)	Low	High	Low	High
Retail adjusted EBITDA	1.75	1.95	1.75	1.95
Potash sales volumes (million tonnes)²	14.1	14.8	14.1	14.8
Nitrogen sales volumes (million tonnes)²	9.2	9.7	9.2	9.7
Phosphate sales volumes (million tonnes)²	2.4	2.6	2.4	2.6
Depreciation and amortization	2.4	2.5	2.4	2.5
Finance costs	0.65	0.75	0.65	0.75
Effective tax rate on adjusted net earnings (%)³	24.0	26.0	24.0	26.0
Capital expenditures⁴	2.0	2.1	2.0	2.1
1 See the "Forward-Looking Statements" section.
2 Manufactured product only.
3 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.
4 Comprised of sustaining capital expenditures, investing capital expenditures and mine development and pre-stripping capital expenditures, which are supplementary financial measures. See the "Other Financial Measures" section.

Consolidated Results

	Three Months Ended March 31
($ millions, except as otherwise noted)	2026	2025	% Change
Sales	6,046	5,100	19
Gross margin	1,646	1,320	25
Expenses	1,286	1,094	18
Net earnings	139	19	n/m
Adjusted EBITDA¹	1,105	852	30
Diluted net earnings per share (dollars)²	0.27	0.02	n/m
Adjusted net earnings per share (dollars)^{1, 2}	0.51	0.11	n/m
1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.
2 All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.

Net earnings and adjusted EBITDA increased in the first quarter of 2026 primarily due to higher fertilizer global benchmarks, increased Retail earnings and record Potash sales volumes compared to the first quarter of 2025.

Segment Results

Our discussion of segment results set out on the following pages is a comparison of the results for the three months ended March 31, 2026 to the results for the three months ended March 31, 2025, unless otherwise noted.

Retail

	Three Months Ended March 31
($ millions, except as otherwise noted)	2026	2025	% Change
Sales	3,640	3,090	18
Cost of goods sold	2,840	2,404	18
Gross margin	800	686	17
Adjusted EBITDA¹	108	46	135
1 See Note 2 to the interim financial statements.

Retail adjusted EBITDA increased in the first quarter of 2026 due to higher crop nutrient sales volumes and stronger proprietary products gross margins in the US and Australia. Expenses increased due to selling expenses related to higher sales volumes.

	Three Months Ended March 31
	Sales		Gross Margin
($ millions)	2026	2025	2026	2025
Crop nutrients	1,483	1,194	250	219
Crop protection products	1,137	972	226	191
Seed	562	532	84	70
Services and other	175	146	144	118
Merchandise	223	189	36	31
Nutrien Financial	80	70	80	70
Nutrien Financial elimination¹	(20)	(13)	(20)	(13)
Total	3,640	3,090	800	686
1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

Crop nutrients sales and gross margin increased in the first quarter of 2026 due to higher sales volumes from our core geographies, including an earlier start to field activity in the US relative to the same period in 2025.

Crop protection products sales and gross margin increased in the first quarter of 2026 due to higher sales of proprietary products, supported by earlier field activity in the US relative to the same period in 2025.

Seed sales and gross margin increased in the first quarter of 2026 due to higher sales volumes, including higher-margin canola seed.

Services and other sales and gross margin increased in the first quarter of 2026 due to a strong livestock market in Australia.

Supplemental Data	Three Months Ended March 31
	Gross Margin		% of Product Line¹
($ millions, except as otherwise noted)	2026	2025	2026	2025
Proprietary products
Crop nutrients	80	69	32	31
Crop protection products	88	53	38	28
Seed	21	28	25	40
Merchandise	2	3	6	9
Total	191	153	24	22
1 Represents percentage of proprietary product margins over total product line gross margin.

	Three Months Ended March 31
	Sales Volumes (tonnes – thousands)		Gross Margin / Tonne (dollars)
	2026	2025	2026	2025
Crop nutrients
North America	1,600	1,464	131	130
International	848	826	48	34
Total	2,448	2,290	102	95

(percentages)	March 31, 2026	December 31, 2025
Financial performance measures^{1, 2}
Cash operating coverage ratio	62	62
Average working capital to sales	23	22
1 Rolling four quarters.
2 These are non-GAAP financial measures. See the "Non-GAAP Financial Measures" section.

Potash

	Three Months Ended March 31
($ millions, except as otherwise noted)	2026	2025	% Change
Net sales	926	744		24
Cost of goods sold	422	380		11
Gross margin	504	364		38
Adjusted EBITDA¹	578	446		30
1 See Note 2 to the interim financial statements.

Potash adjusted EBITDA increased in the first quarter of 2026 due to higher global benchmarks and record sales volumes. We increased potash production and continued to progress mine automation, maintaining our controllable cash cost of product manufactured¹ below $60 per tonne.

Manufactured Product	Three Months Ended March 31
($ per tonne, except as otherwise noted)	2026	2025
Sales volumes (tonnes – thousands)
North America	1,285	1,312
Offshore	2,225	2,090
Total sales volumes	3,510	3,402
Net selling price
North America	287	243
Offshore	250	204
Average net selling price	264	219
Cost of goods sold	120	112
Gross margin	144	107
Depreciation and amortization	50	46
Gross margin excluding depreciation and amortization¹	194	153
1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

Sales volumes in the first quarter of 2026 were the highest on record, supported by low inventory levels and favorable potash affordability in key offshore markets.

Net selling price per tonne increased in the first quarter of 2026 due to higher global benchmark prices.

Cost of goods sold per tonne increased in the first quarter of 2026 primarily due to higher depreciation. Controllable cash cost of product manufactured per tonne decreased in the first quarter of 2026 due to higher potash production.

Supplemental Data	Three Months Ended March 31
	2026	2025
Production volumes (tonnes – thousands)	3,660	3,289
Potash controllable cash cost of product manufactured per tonne¹	59	60
Canpotex sales by market (percentage of sales volumes)²
Latin America	41	31
Other Asian markets³	30	32
China	17	17
India	1	4
Other markets	11	16
Total	100	100
1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.
2 See Note 8 to the interim financial statements.
3 All Asian markets except China and India.

Nitrogen

	Three Months Ended March 31
($ millions, except as otherwise noted)	2026	2025^{1, 2}	% Change
Net sales	1,014	885		15
Cost of goods sold	647	598		8
Gross margin	367	287		28
Adjusted EBITDA²	482	405		19
1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.
2 See Note 2 to the interim financial statements.

Nitrogen adjusted EBITDA increased in the first quarter of 2026 primarily due to higher global benchmarks. Our low-cost North American nitrogen plants delivered an ammonia operating rate² of 92 percent in the first quarter of 2026, consistent with our planned production and reflective of a continued focus on reliability initiatives.

Manufactured Product	Three Months Ended March 31
($ per tonne, except as otherwise noted)	2026	2025
Sales volumes (tonnes – thousands)
Ammonia	298	496
Urea and ESN^®	748	795
Solutions, nitrates and sulfates	1,295	1,178
Total sales volumes	2,341	2,469
Net selling price
Ammonia	479	418
Urea and ESN^®	515	438
Solutions, nitrates and sulfates	282	236
Average net selling price	381	337
Cost of goods sold	225	224
Gross margin	156	113
Depreciation and amortization	65	58
Gross margin excluding depreciation and amortization¹	221	171
1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

Sales volumes decreased in the first quarter of 2026, reflecting no production from the Trinidad and New Madrid facilities⁴, partially offset by higher solutions, nitrates and sulfates sales volumes supported by reliability and debottleneck initiatives.

Net selling price per tonne was higher in the first quarter of 2026 for all major nitrogen products due to stronger global benchmark prices.

Cost of goods sold per tonne was flat in the first quarter of 2026, as lower overall natural gas costs were offset by higher depreciation and other variable costs. The lower overall natural gas cost reflects a higher proportion of production from our low-cost North American nitrogen plants compared to the same period of 2025.

Supplemental Data	Three Months Ended March 31
	2026	2025
Sales volumes (tonnes – thousands)
Fertilizer	1,409	1,389
Industrial and feed	932	1,080
Production volumes (tonnes – thousands)
Ammonia production – total¹	1,122	1,543
Ammonia production – adjusted^{1, 2}	1,019	1,076
Ammonia operating rate (%)²	92	98
Natural gas costs (dollars per MMBtu)
Overall natural gas cost excluding realized derivative impact	3.28	3.91
Realized derivative impact³	‐	‐
Overall natural gas cost	3.28	3.91
1 All figures are provided on a gross production basis in thousands of product tonnes.
2 Excludes Trinidad and Joffre.
3 Includes realized derivative impacts recorded as part of cost of goods sold or other income and expenses.
4 As previously disclosed, on October 23, 2025, the Trinidad nitrogen facility completed a controlled shutdown and we ceased production at our New Madrid nitrogen upgrade facility at year-end 2025.

Phosphate

	Three Months Ended March 31
($ millions, except as otherwise noted)	2026	2025	% Change
Net sales	485	360		35
Cost of goods sold	489	361		35
Gross margin	(4)	(1)		n/m
Adjusted EBITDA¹	57	61		(7)
1 See Note 2 to the interim financial statements.

Phosphate adjusted EBITDA decreased in the first quarter of 2026 due to higher sulfur input costs, partially offset by higher global benchmarks and sales volumes compared to the same period of 2025.

Manufactured Product	Three Months Ended March 31
($ per tonne, except as otherwise noted)	2026	2025
Sales volumes (tonnes – thousands)
Fertilizer	468	332
Industrial and feed	190	168
Total sales volumes	658	500
Net selling price
Fertilizer	668	656
Industrial and feed	883	817
Average net selling price	730	710
Cost of goods sold	726	700
Gross margin	4	10
Depreciation and amortization	109	144
Gross margin excluding depreciation and amortization¹	113	154
1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

Sales volumes were higher in the first quarter of 2026 due to higher production volumes from reliability improvements compared to the same period of 2025.

Net selling price per tonne increased in the first quarter of 2026 due to stronger global benchmark prices.

Cost of goods sold per tonne increased in the first quarter of 2026 primarily due to higher sulfur input costs, more than offsetting higher production volumes that improved cost absorption and lowered depreciation per tonne compared to the same period of 2025.

Supplemental Data	Three Months Ended March 31
	2026	2025
Production volumes (P₂O₅ tonnes – thousands)	337	282
P₂O₅ operating rate (%)	80	67

Corporate and Others and Eliminations

	Three Months Ended March 31
($ millions, except as otherwise noted)	2026	2025^{1, 2}	% Change
Corporate and Others
Gross margin²	14	14	‐
Selling recovery	(3)	(3)	‐
General and administrative expenses	111	99	12
Share-based compensation expense	116	42	176
Foreign exchange loss, net of related derivatives	5	7	(29)
Other expenses	10	18	(44)
Adjusted EBITDA²	(84)	(78)	8
Eliminations
Gross margin	(35)	(30)	17
Adjusted EBITDA²	(36)	(28)	29
1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.
2 See Note 2 to the interim financial statements.

Share-based compensation expense was higher in the first quarter of 2026 due to an increase in the fair value of our share-based awards. The fair value of our share-based awards takes into consideration several factors, such as our share price movement, our performance relative to our peer group and our return on invested capital.

Finance Costs, Income Taxes and Other Comprehensive (Loss) Income

	Three Months Ended March 31
($ millions, except as otherwise noted)	2026	2025	% Change
Finance costs	176	179	(2)
Income taxes
Income tax expense	45	28	61
Actual effective tax rate including discrete items (%)	24	60	(60)
Other comprehensive income	66	25	164

Income tax expense increased in the first quarter of 2026 mainly due to higher earnings. The actual effective tax rate including discrete items decreased due to a change in the proportion of earnings (loss) between tax jurisdictions.

Liquidity and Capital Resources

Sources and uses of liquidity

We continued to manage our capital in accordance with our capital allocation strategy. We believe that our internally generated cash flow, supplemented by available borrowings under new or existing financing sources, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements for the foreseeable future. Refer to the "Capital Structure and Management" section for details on our existing long-term debt and credit facilities.

Sources and uses of cash

	Three Months Ended March 31
($ millions, except as otherwise noted)	2026	2025	% Change
Cash used in operating activities	(851)	(1,082)	(21)
Cash used in investing activities	(487)	(243)	100
Cash provided by financing activities	1,426	1,365	4
Cash used for dividends and share repurchases¹	(409)	(413)	(1)
1 This is a supplementary financial measure. See the "Other Financial Measures" section.

Cash used in operating activities		Cash used in operating activities in the first quarter of 2026 was lower compared to the same period in 2025 primarily due to higher fertilizer global benchmarks, increased Retail earnings and record Potash sales volumes.
Cash used in investing activities		Cash used in investing activities in the first quarter of 2026 was higher compared to the same period in 2025 due to higher cash used on business acquisitions in 2026. The 2025 comparative period included proceeds from the disposal of our investment in Sinofert Holdings Limited.
Cash provided by financing activities		Cash provided by financing activities in the first quarter of 2026 was higher compared to the same period in 2025 due to higher commercial paper issuances in 2026. Additionally, in 2025, we issued $1.0 billion of senior notes. We had no issuances of senior notes in the first quarter of 2026.
Cash used for dividends and share repurchases		Cash used for dividends and share repurchases was consistent in the first quarter of 2026 compared to the same period in 2025.

Financial Condition Review

The following is a comparison of balance sheet categories that are considered material:

	As at
($ millions, except as otherwise noted)	March 31, 2026	December 31, 2025	$ Change	% Change
Assets
Cash and cash equivalents	777	701	76	11
Receivables	6,284	5,675	609	11
Inventories	8,681	6,977	1,704	24
Prepaid expenses and other current assets	733	1,396	(663)	(47)
Property, plant and equipment	22,659	22,747	(88)	‐
Liabilities and Shareholders' Equity
Short-term debt	2,766	873	1,893	217
Trade, other payables and accrued liabilities	9,137	9,309	(172)	(2)
Long-term debt, including current portion	9,861	9,863	(2)	‐
Share capital	13,515	13,519	(4)	‐
Retained earnings	11,853	12,076	(223)	(2)

Explanations for changes in Cash and cash equivalents are in the "Liquidity and Capital Resources - Sources and uses of cash" section.

Receivables increased due to higher fertilizer global benchmarks and the seasonality of our Retail segment, resulting in higher receivables with customers and vendor rebates, partially offset by improved collection of receivables in North America. Receivables also increased from record Potash sales volumes.

Inventories increased due to the seasonality of our Retail segment. Our North American inventory levels generally increase at year-end, peak in the first quarter of the year in preparation for the planting and application seasons, and are drawn down in the succeeding quarters.

Prepaid expenses and other current assets decreased due to Retail taking delivery of prepaid inventories in preparation for the spring planting and applications season in North America.

Short-term debt increased due to higher commercial paper issuances to support working capital requirements driven by the seasonality of our business.

Trade, other payables and accrued liabilities decreased due to the settlement in the first quarter of 2026 of our Retail supplier financing arrangement obligations that were entered into in the fourth quarter of 2025. This was partially offset by higher Retail customer prepayments received in the first quarter of 2026 in anticipation of crop input price increases.

Capital Structure and Management

Principal debt instruments

As part of the normal course of business, we closely monitor our liquidity position. We use a combination of cash generated from operations and short-term and long-term debt to finance our operations. We continually evaluate various financing arrangements and may seek to engage in transactions from time to time when market and other conditions are favorable. We were in compliance with our debt covenants and did not have any changes to our credit ratings for the three months ended March 31, 2026.

Capital structure (debt and equity)

($ millions)	March 31, 2026	December 31, 2025
Short-term debt	2,766	873
Current portion of long-term debt	1,036	513
Current portion of lease liabilities	362	346
Long-term debt	8,825	9,350
Lease liabilities	957	937
Shareholders' equity	25,192	25,365

Commercial paper, credit facilities and other debt

We have a total facility limit of approximately $7,426 million comprised of several credit facilities available in the jurisdictions where we operate. In North America, we have a commercial paper program, which is limited to the undrawn amount under our $4,500 million unsecured revolving term credit facility and excess cash invested in highly liquid securities.

As at March 31, 2026, we utilized $2,780 million of our total facility limit, which includes $2,421 million of commercial paper outstanding. In the first quarter of 2026, we extended the maturity of our accounts receivable purchase facility from March 6, 2026 to March 31, 2028 and entered into a $69 million uncommitted revolving demand facility.

As at March 31, 2026, $234 million in letters of credit were outstanding and committed, with $352 million of remaining credit available under our letter of credit facilities.

Our long-term debt consists primarily of notes and debentures. See the "Capital Structure and Management" section of our 2025 Annual Report for information on balances, rates and maturities for our notes and debentures.

Outstanding share data

	As at May 5, 2026
Common shares	480,023,548
Options to purchase common shares	1,921,277

For more information on our capital management, see Note 4 to the annual financial statements in our 2025 Annual Report.

Quarterly Results

($ millions, except as otherwise noted)	Q1 2026	Q4 2025		Q3 2025		Q2 2025		Q1 2025		Q4 2024		Q3 2024		Q2 2024
Sales	6,046		5,340		6,007		10,438		5,100		5,079		5,348		10,156
Net earnings	139		580		469		1,229		19		118		25		392
Net earnings attributable to equity holders of Nutrien	131		571		464		1,221		11		113		18		385
Net earnings per share attributable to equity holders of Nutrien
Basic	0.27		1.18		0.96		2.51		0.02		0.23		0.04		0.78
Diluted	0.27		1.18		0.96		2.50		0.02		0.23		0.04		0.78

Our quarterly earnings are significantly affected by the seasonality of our business, fertilizer benchmark prices, global demand-supply conditions, grower affordability and weather. See Note 2 to the interim financial statements.

Accounting Policies and New IFRS Standards

Significant accounting policies are disclosed in our 2025 Annual Report and have been consistently applied for the three months ended March 31, 2026, except as described below.

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, were adopted effective January 1, 2026, the required adoption date. The impact was not material. On initial adoption, there was an adjustment of $(13) million to opening cash and cash equivalents as at January 1, 2026, which has been reflected in the condensed consolidated statement of cash flows for the three months ended March 31, 2026.

Critical Accounting Estimates

The preparation of financial statements in accordance with IFRS requires management to make estimates and judgments that affect reported assets, liabilities, revenues and expenses. We have discussed the development, selection and application of our key accounting policies, and the critical accounting estimates and assumptions they involve, with the Audit Committee of the Board.

Our critical accounting estimates are discussed on pages 64 to 65 of our 2025 Annual Report. There were no material changes to our critical accounting estimates for the three months ended March 31, 2026.

Controls and Procedures

Management is responsible for establishing and maintaining adequate internal control over financial reporting ("ICFR"), as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended, and National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings. ICFR is designed to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with IFRS. Any system of ICFR, no matter how well designed, has inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

There has been no change in our ICFR during the three months ended March 31, 2026, that has materially affected, or is reasonably likely to materially affect, our ICFR.

Forward-Looking Statements

Certain statements and other information included in this document, including within the "Market Outlook and Guidance" section, constitute "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") under applicable securities laws (such statements are often accompanied by words such as "anticipate", "forecast", "expect", "believe", "may", "will", "should", "estimate", "project", "intend" or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to: Nutrien's business strategies, plans, prospects and opportunities; Nutrien's 2026 full-year guidance, including expectations regarding Retail adjusted EBITDA, Potash sales volumes, Nitrogen sales volumes, Phosphate sales volumes, depreciation and amortization, finance costs, effective tax rate on adjusted net earnings and capital expenditures, including the assumptions and expectations stated therein; expectations regarding the review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business and associated outcomes; expectations regarding structural growth in our downstream business; expectations regarding our capital allocation approach and strategies, including our intentions with respect to our strategic actions and the expected timing thereof; our expectations regarding Nutrien's strategic priorities and our ability to advance and achieve such strategic priorities in 2026 and beyond; expectations regarding various performance targets in 2026 and beyond and our ability to achieve such targets; capital spending expectations for 2026 and beyond; expectations regarding performance of our operating segments in 2026 and beyond; the expectation that internally generated cash flow, supplemented by available borrowings, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements; expectations regarding payment of dividends and share repurchases; our operating segment market outlooks and our expectations for market conditions and fundamentals, and the anticipated supply and demand for our products and services, crop input demand, expected market, industry and growing conditions with respect to crop nutrient application rates, planted acres, farmer crop investment, crop mix and the need to replenish soil nutrient levels, input costs, production volumes and expenses, shipments, natural gas costs and availability, consumption, prices, operating rates, the impact of seasonality, import and export volumes, tariffs, trade or export restrictions, economic sanctions and restrictions, geopolitical disruptions, including the ongoing conflict in the Middle East, inventories, crop development, and natural gas curtailments; the negotiation of sales contracts; acquisitions and divestitures and the anticipated benefits thereof; and expectations in connection with our ability to generate free cash flow, enhance earnings quality, and deliver long-term returns to shareholders.

These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty.

The additional key assumptions that have been made in relation to the operation of our business as currently planned and our ability to achieve our business objectives include, among other things, assumptions with respect to: our ability to successfully implement our business strategies, growth and capital allocation investments and initiatives; that we will conduct our operations and achieve results of operations as anticipated; growth in crop nutrient sales volumes and gross margins; our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures, and that we will be able to implement our standards, controls, procedures and policies in respect of any acquired businesses and realize the expected synergies on the anticipated timeline or at all; increased proprietary products gross margin; successful execution of the review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business, within the anticipated timing and parameters, and realization of the expected benefits therefrom; continued reliability improvements; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, expenses, margins, operating rates, demand, supply, product availability, shipments, consumption, weather conditions, supplier agreements, product distribution agreements, inventory levels, exports, tariffs, including general or retaliatory tariffs, trade restrictions, international trade arrangements, government support, crop development and cost of labor and interest, exchange and effective tax rates; global economic conditions and the accuracy of our market outlook expectations for 2026 and in the future; assumptions related to our assessment of recoverable amount estimates of our assets; our intention to complete share repurchases under our normal course issuer bid programs, the funding of such share repurchases, existing and future market conditions, including with respect to the price of our common shares, capital allocation priorities and compliance with respect to applicable limitations under securities laws and regulations and stock exchange policies and assumptions related to our ability to fund our dividends at the current level; our expectations regarding the impacts, direct and indirect, of certain geopolitical conflicts, including the ongoing conflict in the Middle East, on, among other things, global supply and demand, including for crop nutrients, energy and commodity prices, global interest rates, supply chains and the global macroeconomic environment, including inflation; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; the availability of investment opportunities that align with our strategic priorities and growth strategy; our ability to maintain investment grade ratings and achieve our performance targets; and our ability to successfully negotiate sales and other contracts and our ability to successfully implement new initiatives and programs.

Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to achieve expected results of our business strategy, capital allocation initiatives, results of operations or targets; failure to complete announced and future strategic and asset optimization initiatives, acquisitions or divestitures at all or on the expected terms and within the expected timeline; seasonality of our business; climate change and weather conditions, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including general or retaliatory tariffs, trade restrictions, or other changes to international trade arrangements) and regulatory investigations; current and future litigation proceedings; the results of our review of strategic alternatives for our Phosphate business, Trinidad Nitrogen facility and Brazilian Retail business, including the process and the timing thereof, and whether the review will result in Nutrien undertaking a transaction, including the terms and timing relating thereto, the completion thereof and the benefits to be realized therefrom; the effects of current and future multinational trade agreements or other developments affecting the level of trade or export restrictions; government ownership requirements, changes in environmental, tax, antitrust and other laws or regulations and the interpretation thereof; political or military risks, including civil unrest, actions by armed groups or conflict and malicious acts, including terrorism and industrial espionage; our ability to access sufficient, cost-effective and timely transportation, distribution and storage of products (including potential rail transportation and port disruptions due to labor strikes and/or work stoppages or other similar actions); the occurrence of a major environmental or safety incident or becoming subject to legal or regulatory proceedings; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities or challenges related to our major facilities that are out of our control; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; the risk that rising interest rates and/or deteriorated business operating results may result in the further impairment of assets or goodwill attributed to certain of our cash generating units; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; geopolitical conflicts, including the ongoing conflict in the Middle East, and their potential impact on, among other things, global market conditions and supply and demand, including for crop nutrients, energy and commodity prices, interest rates, supply chains and the global economy generally; our ability to execute on our strategies related to environmental, social and governance matters, and achieve related expectations, targets and commitments, including risks associated with disclosure thereof; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the SEC.

The purpose of our Retail adjusted EBITDA, depreciation and amortization, finance costs, effective tax rate and capital expenditures guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.

Terms and Definitions

For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the "Terms and definitions" section of our 2025 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, "n/m" indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.

About Nutrien

Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve farmers. Our vision is to be the leading global agricultural solutions provider, delivering superior shareholder value through safe and sustainable operations. To achieve this vision, our strategy is anchored in three priorities: simplify and focus, operational excellence and a disciplined and intentional approach to capital allocation. This strategy is designed to create low-risk, structural free cash flow growth by leveraging our core competencies and to deliver reliable, growing cash returns to shareholders.

More information about Nutrien can be found at www.nutrien.com.

Selected financial data for download can be found in our data tool at https://www.nutrien.com/investors/interactive-data-tool

Such data is not incorporated by reference herein.

Nutrien will host a Conference Call on Thursday, May 7, 2026 at 10:00 a.m. Eastern Time.

Telephone conference dial-in numbers:

From Canada and the US: 1-800-990-2777
International: 1-416-855-9085
Conference ID: 89180. Please dial in 15 minutes prior to ensure you are placed on the call in a timely manner.

Live Audio Webcast: Visit https://www.nutrien.com/news/events/2026-q1-earnings-conference-call

Non-GAAP Financial Measures

We use both IFRS measures and certain non-GAAP financial measures to assess performance. Non-GAAP financial measures are financial measures disclosed by the Company that: (a) depict historical or expected future financial performance, financial position or cash flow of the Company; (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the Company; (c) are not disclosed in the financial statements of the Company; and (d) are not a ratio, fraction, percentage or similar representation. Non-GAAP ratios are financial measures disclosed by the Company that are in the form of a ratio, fraction, percentage or similar representation that has a non-GAAP financial measure as one or more of its components, and that are not disclosed in the financial statements of the Company.

These non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-GAAP financial measures and non-GAAP ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-GAAP financial measures and non-GAAP ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

The following section outlines our non-GAAP financial measures and non-GAAP ratios, their compositions, and why management uses each measure. It also includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-GAAP financial measures and non-GAAP ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

Adjusted EBITDA (Consolidated)

Most directly comparable IFRS financial measure: Net earnings (loss).

Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on sale of certain businesses and investments, asset retirement obligations ("ARO") and accrued environmental costs ("ERL") related to our non-operating sites, and loss related to financial instruments in Argentina.

Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations and as a component of employee remuneration calculations.

	Three Months Ended March 31
($ millions)	2026	2025
Net earnings	139	19
Finance costs	176	179
Income tax expense	45	28
Depreciation and amortization	606	571
EBITDA¹	966	797
Adjustments:
Share-based compensation expense	116	42
Foreign exchange loss, net of related derivatives	5	7
ARO/ERL related (income) expenses for non-operating sites	(28)	5
Restructuring costs	16	1
Impairment of assets recorded in other income and expenses	30	‐
Adjusted EBITDA	1,105	852
1 EBITDA is calculated as net earnings before finance costs, income taxes, and depreciation and amortization.

Adjusted Net Earnings and Adjusted Net Earnings Per Share

Most directly comparable IFRS financial measure: Net earnings (loss) and diluted net earnings (loss) per share.

Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on sale of certain businesses and investments, gain or loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting, asset retirement obligations and accrued environmental costs related to our non-operating sites, loss related to financial instruments in Argentina, change in recognition of tax losses and deductible temporary differences related to impairments and certain changes to tax declarations. We generally apply the annual forecasted effective tax rate to specific adjustments during the year, and at year-end, we apply the actual effective tax rate.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

	Three Months Ended March 31, 2026
			Per
	Increases		Diluted
($ millions, except as otherwise noted)	(Decreases)	Post-Tax	Share
Net earnings attributable to equity holders of Nutrien		131	0.27
Adjustments:
Share-based compensation expense	116	88	0.18
Foreign exchange loss, net of related derivatives	5	10	0.02
Restructuring costs	16	16	0.03
Impairment of assets recorded in other income and expenses	30	22	0.05
ARO/ERL related (income) for non-operating sites	(28)	(22)	(0.04)
Sub-total adjustments	139	114	0.24
Adjusted net earnings		245	0.51

	Three Months Ended March 31, 2025
			Per
	Increases		Diluted
($ millions, except as otherwise noted)	(Decreases)	Post-Tax	Share
Net earnings attributable to equity holders of Nutrien		11	0.02
Adjustments:
Share-based compensation expense	42	31	0.06
Foreign exchange loss, net of related derivatives	7	6	0.01
Restructuring costs	1	1	‐
ARO/ERL related expenses for non-operating sites	5	4	0.02
Sub-total adjustments	55	42	0.09
Adjusted net earnings		53	0.11

Effective Tax Rate on Adjusted Net Earnings

Effective tax rate on adjusted net earnings guidance is a forward-looking non-GAAP financial measure as it includes adjusted net earnings, which is a non-GAAP financial measure. It is provided to assist readers in understanding our expected financial results. Effective tax rate on adjusted net earnings guidance excludes certain items that management is aware of that permit management to focus on the performance of our operations (see the Adjusted Net Earnings and Adjusted Net Earnings Per Share section for items generally adjusted). We do not provide a reconciliation of this forward-looking measure to the most directly comparable financial measures calculated and presented in accordance with IFRS because a meaningful or accurate calculation of reconciling items and the information is not available without unreasonable effort due to unknown variables, including the timing and amount of certain reconciling items, and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. The probable significance of such unavailable information, which could be material to future results, cannot be addressed.

Gross Margin Excluding Depreciation and Amortization Per Tonne – Manufactured Product

Most directly comparable IFRS financial measure: Gross margin.

Definition: Gross margin per tonne less depreciation and amortization per tonne for manufactured products. Reconciliations are provided in the "Segment Results" section.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

Potash Controllable Cash Cost of Product Manufactured ("COPM") Per Tonne

Most directly comparable IFRS financial measure: Cost of goods sold ("COGS") for the Potash segment.

Definition: Total Potash COGS excluding depreciation and amortization expense included in COPM, royalties, natural gas costs and carbon taxes, change in inventory, and other adjustments, divided by potash production tonnes.

Why we use the measure and why it is useful to investors: To assess operational performance. Potash controllable cash COPM excludes the effects of production from other periods and the impacts of our long-term investment decisions, supporting a focus on the performance of our day-to-day operations. Potash controllable cash COPM also excludes royalties and natural gas costs and carbon taxes, which management does not consider controllable, as they are primarily driven by regulatory and market conditions.

	Three Months Ended March 31
($ millions, except as otherwise noted)	2026	2025
Total COGS – Potash	422	380
Change in inventory	8	7
Other adjustments¹	(5)	(13)
COPM	425	374
Depreciation and amortization in COPM	(171)	(145)
Royalties in COPM	(26)	(19)
Natural gas costs and carbon taxes in COPM	(13)	(12)
Controllable cash COPM	215	198
Production volumes (tonnes – thousands)	3,660	3,289
Potash controllable cash COPM per tonne	59	60
1 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

Retail Cash Operating Coverage Ratio

Definition: Retail selling, general and administrative, and other expenses (income), excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate cash flow.

	Rolling Four Quarters Ended March 31, 2026
($ millions, except as otherwise noted)	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Total
Selling expenses	948	792	811	798	3,349
General and administrative expenses	44	44	40	44	172
Other expenses	54	40	4	36	134
Operating expenses	1,046	876	855	878	3,655
Depreciation and amortization in operating expenses	(172)	(179)	(184)	(179)	(714)
Operating expenses excluding depreciation and amortization	874	697	671	699	2,941

Gross margin	2,018	922	977	800	4,717
Depreciation and amortization in cost of goods sold	5	5	5	5	20
Gross margin excluding depreciation and amortization	2,023	927	982	805	4,737
Cash operating coverage ratio (%)					62

	Rolling Four Quarters Ended December 31, 2025
($ millions, except as otherwise noted)	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Total
Selling expenses	755	948	792	811	3,306
General and administrative expenses	44	44	44	40	172
Other expenses	25	54	40	4	123
Operating expenses	824	1,046	876	855	3,601
Depreciation and amortization in operating expenses	(179)	(172)	(179)	(184)	(714)
Operating expenses excluding depreciation and amortization	645	874	697	671	2,887

Gross margin	686	2,018	922	977	4,603
Depreciation and amortization in cost of goods sold	5	5	5	5	20
Gross margin excluding depreciation and amortization	691	2,023	927	982	4,623
Cash operating coverage ratio (%)					62

Retail Average Working Capital to Sales

Definition: Retail average working capital divided by Retail sales for the last four rolling quarters.

Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively.

	Rolling Four Quarters Ended March 31, 2026
($ millions, except as otherwise noted)	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Average/Total
Current assets	11,442	10,823	11,185	12,558
Current liabilities	(8,051)	(5,348)	(8,275)	(7,799)
Working capital	3,391	5,475	2,910	4,759	4,134

Sales	7,959	3,427	3,144	3,640	18,170
Average working capital to sales (%)					23

	Rolling Four Quarters Ended December 31, 2025
($ millions, except as otherwise noted)	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Average/Total
Current assets	11,510	11,442	10,823	11,185
Current liabilities	(7,561)	(8,051)	(5,348)	(8,275)
Working capital	3,949	3,391	5,475	2,910	3,931

Sales	3,090	7,959	3,427	3,144	17,620
Average working capital to sales (%)					22

Other Financial Measures

Selected Additional Financial Data

Nutrien Financial Aging		As at March 31, 2026						As at December 31, 2025
($ millions)	Current	<31 Days past due	31–90 Days past due	>90 Days past due	Gross receivables	Allowance¹	Net receivables²	Net receivables
North America	1,566	89	223	196	2,074	(55)	2,019	2,332
International	879	64	53	26	1,022	(6)	1,016	774
Nutrien Financial receivables	2,445	153	276	222	3,096	(61)	3,035	3,106
1 Bad debt expense on the above receivables for the three months ended March 31, 2026 was $9 million, in the Retail segment.
2 In 2026, we assume a debt-to-equity ratio of 9:1 (2025 – 9:1) in funding Nutrien Financial receivables, based on the underlying credit quality of the assets.

Nutrien Financial Net Receivables	Rolling Four Quarters Ended March 31, 2026
($ millions, except as otherwise noted)	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Average/Total
Average Nutrien Financial net receivables	4,645	4,452	3,106	3,035	3,810

Supplementary Financial Measures

Supplementary financial measures are financial measures disclosed by the Company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company, (b) are not disclosed in the financial statements of the Company, (c) are not non-GAAP financial measures, and (d) are not non-GAAP ratios.

The following section provides an explanation of the composition of those supplementary financial measures, if not previously provided.

Sustaining capital expenditures: Represents capital expenditures that are required to sustain operations at existing levels and include major repairs and maintenance and plant turnarounds.

Investing capital expenditures: Represents capital expenditures related to significant expansions of current operations or to create cost savings (synergies). Investing capital expenditures exclude capital outlays for business acquisitions and equity-accounted investees.

Mine development and pre-stripping capital expenditures: Represents capital expenditures that are required for activities to open new areas underground and/or develop a mine or ore body to allow for future production mining and activities required to prepare and/or access the ore, i.e., removal of an overburden that allows access to the ore.

Cash used for dividends and share repurchases: Calculated as dividends paid to Nutrien's shareholders plus repurchase of common shares as reflected in the unaudited condensed consolidated statements of cash flows. This measure is useful as it represents return of cash to shareholders.

Condensed Consolidated Financial Statements

Unaudited

Condensed Consolidated Statements of Earnings

		Three Months Ended
		March 31
($ millions, except as otherwise noted)	Note	2026	2025
Sales	2, 8	6,046	5,100
Freight, transportation and distribution		244	226
Cost of goods sold		4,156	3,554
Gross Margin		1,646	1,320
Selling expenses		799	757
General and administrative expenses		164	152
Provincial mining taxes		90	68
Share-based compensation expense		116	42
Foreign exchange loss, net of related derivatives		3	7
Other expenses	3	114	68
Earnings Before Finance Costs and Income Taxes		360	226
Finance costs		176	179
Earnings Before Income Taxes		184	47
Income tax expense	4	45	28
Net Earnings		139	19
Attributable to
Equity holders of Nutrien		131	11
Non-controlling interest		8	8
Net Earnings		139	19

Net Earnings Per Share Attributable to Equity Holders of Nutrien ("EPS")
Basic		0.27	0.02
Diluted		0.27	0.02
Weighted average shares outstanding for basic EPS		481,260,000	489,397,000
Weighted average shares outstanding for diluted EPS		481,647,000	489,540,000

(See Notes to the Condensed Consolidated Financial Statements)

Condensed Consolidated Statements of Comprehensive Income

	Three Months Ended
	March 31
($ millions, net of related income taxes)	2026	2025
Net Earnings	139	19
Other comprehensive income
Items that will not be reclassified to net earnings:
Net fair value loss on investments	‐	(18)
Items that have been or may be subsequently reclassified to net earnings:
Gain on currency translation of foreign operations	72	39
Other	(6)	4
Other Comprehensive Income	66	25
Comprehensive Income	205	44
Attributable to
Equity holders of Nutrien	196	36
Non-controlling interest	9	8
Comprehensive Income	205	44

(See Notes to the Condensed Consolidated Financial Statements)

Condensed Consolidated Statements of Cash Flows

		Three Months Ended
		March 31
($ millions)	Note	2026	2025
Operating Activities
Net earnings		139	19
Adjustments for:
Depreciation and amortization		606	571
Share-based compensation expense		116	42
Provision for deferred income tax		41	80
Net undistributed earnings of equity-accounted investees		(1)	(5)
Long-term income tax receivables and payables		(15)	(38)
Other long-term assets, liabilities and miscellaneous		27	5
Cash from operations before working capital changes		913	674
Changes in non-cash operating working capital:
Receivables		(530)	(143)
Inventories and prepaid expenses and other current assets		(991)	(1,274)
Trade, other payables and accrued liabilities		(243)	(339)
Cash Used in Operating Activities		(851)	(1,082)
Investing Activities
Capital expenditures¹		(325)	(300)
Business acquisitions, net of cash acquired		(50)	(11)
Purchase of investments, held within three months, net		(8)	(16)
Purchase of investments		‐	(2)
Proceeds from sale of investments		‐	183
Net changes in non-cash working capital		(94)	(88)
Other		(10)	(9)
Cash Used in Investing Activities		(487)	(243)
Financing Activities
Proceeds from debt, maturing within three months, net		1,921	912
Proceeds from debt		‐	998
Repayment of debt		(9)	(4)
Repayment of principal portion of lease liabilities		(100)	(110)
Dividends paid to Nutrien's shareholders	7	(262)	(265)
Repurchase of common shares	7	(147)	(148)
Issuance of common shares		45	3
Other		(22)	(21)
Cash Provided by Financing Activities		1,426	1,365
Effect of Exchange Rate Changes on Cash and Cash Equivalents		1	2
Increase in Cash and Cash Equivalents		89	42
January 1, 2026 opening balance prior to restatement for amendments to IFRS 9	9	701	‐
Adjustment on initial application of amendments to IFRS 9 on January 1, 2026	9	(13)	‐
Cash and Cash Equivalents – Beginning of Period		688	853
Cash and Cash Equivalents – End of Period		777	895
Cash and cash equivalents is composed of:
Cash		712	828
Short-term investments		65	67
		777	895
Supplemental Cash Flows Information
Interest paid		148	132
Income taxes paid		37	7
Total cash outflow for leases		137	150
1 Includes additions to property, plant and equipment, and intangible assets for the three months ended March 31, 2026 of $299 million and $26 million (2025 – $279 million and $21 million).

(See Notes to the Condensed Consolidated Financial Statements)

Condensed Consolidated Statements of Changes in Shareholders' Equity

				Accumulated other comprehensive
				(loss) income ("AOCI")
($ millions, inclusive of related tax, except as otherwise noted)	Number of common shares	Share capital	Contributed surplus	(Loss) gain on currency translation of foreign operations	Other	Total AOCI	Retained earnings	Equity holders of Nutrien	Non- controlling interest	Total equity
Balance – December 31, 2024	491,025,446	13,748	68	(537)	22	(515)	11,106	24,407	35	24,442
Net earnings	‐	‐	‐	‐	‐	‐	11	11	8	19
Other comprehensive income (loss)	‐	‐	‐	39	(14)	25	‐	25	‐	25
Shares repurchased for cancellation (Note 7)	(2,862,814)	(80)	‐	‐	‐	‐	(69)	(149)	‐	(149)
Dividends declared¹	‐	‐	‐	‐	‐	‐	(266)	(266)	‐	(266)
Non-controlling interest transactions	‐	‐	‐	‐	‐	‐	‐	‐	(11)	(11)
Effect of share-based compensation including issuance of common shares	59,751	3	1	‐	‐	‐	‐	4	‐	4
Transfer of net gain on sale of investment	‐	‐	‐	‐	(27)	(27)	27	‐	‐	‐
Transfer of net loss on cash flow hedges	‐	‐	‐	‐	6	6	‐	6	‐	6
Balance – March 31, 2025	488,222,383	13,671	69	(498)	(13)	(511)	10,809	24,038	32	24,070
Balance – December 31, 2025	481,962,233	13,519	57	(329)	‐	(329)	12,076	25,323	42	25,365
Net earnings	‐	‐	‐	‐	‐	‐	131	131	8	139
Other comprehensive income (loss)	‐	‐	‐	71	(6)	65	‐	65	1	66
Shares repurchased for cancellation (Note 7)	(2,081,503)	(58)	‐	‐	‐	‐	(90)	(148)	‐	(148)
Dividends declared¹	‐	‐	‐	‐	‐	‐	(264)	(264)	‐	(264)
Non-controlling interest transactions	‐	‐	‐	‐	‐	‐	‐	‐	(13)	(13)
Effect of share-based compensation including issuance of common shares	876,975	54	(8)	‐	‐	‐	‐	46	‐	46
Transfer of net loss on cash flow hedges	‐	‐	‐	‐	1	1	‐	1	‐	1
Balance – March 31, 2026	480,757,705	13,515	49	(258)	(5)	(263)	11,853	25,154	38	25,192
1 During the three months ended March 31, 2026, we declared dividends of $0.55 per share (2025 - $0.545 per share).

(See Notes to the Condensed Consolidated Financial Statements)

Condensed Consolidated Balance Sheets

				As at
		As at March 31		December 31
($ millions)	Note	2026	2025	2025
Assets
Current assets
Cash and cash equivalents		777	895	701
Receivables	8	6,284	5,612	5,675
Inventories		8,681	7,992	6,977
Prepaid expenses and other current assets		733	863	1,396
		16,475	15,362	14,749
Non-current assets
Property, plant and equipment		22,659	22,488	22,747
Goodwill		12,176	12,058	12,136
Intangible assets		1,621	1,791	1,667
Investments		146	495	144
Other assets		846	875	858
Total Assets		53,923	53,069	52,301
Liabilities
Current liabilities
Short-term debt	6	2,766	2,437	873
Current portion of long-term debt		1,036	1,038	513
Current portion of lease liabilities		362	364	346
Trade, other payables and accrued liabilities	8	9,137	8,752	9,309
		13,301	12,591	11,041
Non-current liabilities
Long-term debt		8,825	9,870	9,350
Lease liabilities		957	998	937
Deferred income tax liabilities		3,701	3,591	3,666
Pension and other post-retirement benefit liabilities		218	225	221
Asset retirement obligations and accrued environmental costs		1,478	1,528	1,468
Other non-current liabilities		251	196	253
Total Liabilities		28,731	28,999	26,936
Shareholders' Equity
Share capital	7	13,515	13,671	13,519
Contributed surplus		49	69	57
Accumulated other comprehensive loss		(263)	(511)	(329)
Retained earnings		11,853	10,809	12,076
Equity holders of Nutrien		25,154	24,038	25,323
Non-controlling interest		38	32	42
Total Shareholders' Equity		25,192	24,070	25,365
Total Liabilities and Shareholders' Equity		53,923	53,069	52,301

(See Notes to the Condensed Consolidated Financial Statements)

Notes to the Condensed Consolidated Financial Statements

As at and for the Three Months Ended March 31, 2026

Note 1 Basis of presentation

Nutrien Ltd. (collectively with its subsidiaries, "Nutrien", "we", "us", "our" or "the Company") is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers.

These unaudited interim condensed consolidated financial statements ("interim financial statements") are based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, "Interim Financial Reporting". The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2025 annual audited consolidated financial statements with the exception of the amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, which were adopted effective January 1, 2026 (refer to Note 9). These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2025 annual audited consolidated financial statements. These interim financial statements are presented in millions of US dollars, unless otherwise indicated, which is the functional currency of Nutrien and the majority of its subsidiaries.

Certain immaterial 2025 figures have been reclassified in Note 2 Segment information.

In management's opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year.

These interim financial statements were authorized by the Audit Committee of the Board of Directors for issue on May 6, 2026.

Note 2 Segment information

We have four reportable operating segments: Retail, Potash, Nitrogen and Phosphate. Our downstream Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides agronomic application services and solutions, including the services offered through Nutrien Financial. Retail also manufactures and distributes proprietary products and provides services directly to farmers through a network of retail locations in North America, Australia and South America. Our upstream Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each segment produces and are supported by midstream activities, which include the global sales, freight, transportation and distribution of our products, which are reported within these segments, respectively. Potash freight, transportation and distribution costs only apply to our North American potash sales volumes. Sales reported under our Corporate and Others segment relates to our non-core businesses. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

In the fourth quarter of 2025, the Chief Operating Decision Maker ("CODM") reassessed our product groupings and determined that the performance of our Purchase for Resale business should be evaluated as part of the Corporate and Others segment. It had previously been presented in our Nitrogen segment. The Purchase for Resale business focuses primarily on sales to international customers. Purchased product that remains in upstream is primarily purchases of inventory to satisfy sales contracts that we cannot fulfill with our manufactured products. The CODM concluded this change was appropriate based on the nature and strategic alignment of purchase for resale activities. Comparative amounts for the Corporate and Others and Nitrogen segments were reclassified. As a result of the reclassification, the Corporate and Others segment reflected the following increases and the Nitrogen segment reflected the corresponding decreases for the three months ended March 31, 2025.

		Three Months Ended
($ millions)		March 31, 2025
Sales		70
Gross Margin		4
EBITDA		3

		Three Months Ended March 31, 2026
		Downstream	Upstream and Midstream
						Corporate
($ millions)		Retail	Potash	Nitrogen	Phosphate	and Others	Eliminations	Consolidated
Sales	– third party	3,640	966	884	478	78	‐	6,046
	– intersegment	‐	75	247	69	‐	(391)	‐
Sales	– total	3,640	1,041	1,131	547	78	(391)	6,046
Freight, transportation and distribution¹		‐	115	117	62	‐	(50)	244
Net sales		3,640	926	1,014	485	78	(341)	5,802
Cost of goods sold		2,840	422	647	489	64	(306)	4,156
Gross margin		800	504	367	(4)	14	(35)	1,646
Selling expenses (recovery)		798	3	6	2	(3)	(7)	799
General and administrative expenses		44	3	4	2	111	‐	164
Provincial mining taxes		‐	90	‐	‐	‐	‐	90
Share-based compensation expense		‐	‐	‐	‐	116	‐	116
Foreign exchange (gain) loss, net of related derivatives		(2)	‐	‐	‐	5	‐	3
Other expenses		36	26	27	7	10	8	114
Earnings (loss) before finance costs and income taxes		(76)	382	330	(15)	(225)	(36)	360
Depreciation and amortization		184	175	152	72	23	‐	606
EBITDA		108	557	482	57	(202)	(36)	966
Restructuring costs (Note 3)		‐	‐	‐	‐	16	‐	16
Share-based compensation expense		‐	‐	‐	‐	116	‐	116
Impairment of assets recorded in other income and expenses (Note 3)		‐	21	‐	‐	9	‐	30
ARO/ERL related income for non-operating sites² (Note 3)		‐	‐	‐	‐	(28)	‐	(28)
Foreign exchange loss, net of related derivatives		‐	‐	‐	‐	5	‐	5
Adjusted EBITDA		108	578	482	57	(84)	(36)	1,105
1 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.
2 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

		Three Months Ended March 31, 2025
		Downstream	Upstream and Midstream
						Corporate
($ millions)		Retail	Potash	Nitrogen¹	Phosphate	and Others¹	Eliminations	Consolidated
Sales	– third party	3,090	766	822	338	84	‐	5,100
	– intersegment	‐	95	182	67	‐	(344)	‐
Sales	– total	3,090	861	1,004	405	84	(344)	5,100
Freight, transportation and distribution²		‐	117	119	45	1	(56)	226
Net sales		3,090	744	885	360	83	(288)	4,874
Cost of goods sold		2,404	380	598	361	69	(258)	3,554
Gross margin		686	364	287	(1)	14	(30)	1,320
Selling expenses (recovery)		755	3	7	2	(3)	(7)	757
General and administrative expenses		44	2	5	2	99	‐	152
Provincial mining taxes		‐	68	‐	‐	‐	‐	68
Share-based compensation expense		‐	‐	‐	‐	42	‐	42
Foreign exchange loss, net of related derivatives		‐	‐	‐	‐	7	‐	7
Other expenses		25	2	12	6	18	5	68
Earnings (loss) before finance costs and income taxes		(138)	289	263	(11)	(149)	(28)	226
Depreciation and amortization		184	157	142	72	16	‐	571
EBITDA		46	446	405	61	(133)	(28)	797
Restructuring costs (Note 3)		‐	‐	‐	‐	1	‐	1
Share-based compensation expense		‐	‐	‐	‐	42	‐	42
ARO/ERL related expenses for non-operating sites (Note 3)		‐	‐	‐	‐	5	‐	5
Foreign exchange loss, net of related derivatives		‐	‐	‐	‐	7	‐	7
Adjusted EBITDA		46	446	405	61	(78)	(28)	852
1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.
2 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

	Three Months Ended
	March 31
($ millions)	2026	2025
Retail sales by product line
Crop nutrients	1,483	1,194
Crop protection products	1,137	972
Seed	562	532
Services and other	175	146
Merchandise	223	189
Nutrien Financial	80	70
Nutrien Financial elimination¹	(20)	(13)
	3,640	3,090
Potash sales by geography
Manufactured product
North America	484	434
Offshore²	557	426
Other potash and purchased products	‐	1
	1,041	861
Nitrogen sales by product line
Manufactured product
Ammonia	167	240
Urea and ESN^®	416	382
Solutions, nitrates and sulfates	416	321
Other nitrogen and purchased products³	132	61
	1,131	1,004
Phosphate sales by product line
Manufactured product
Fertilizer	359	249
Industrial and feed	183	151
Other phosphate and purchased products	5	5
	547	405
1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.
2 Relates to Canpotex Limited ("Canpotex") (see Note 8) and includes provisional pricing adjustments for the three months ended March 31, 2026 of $(3) million (2025 – $31 million).
3 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

Note 3 Other expenses (income)

	Three Months Ended
	March 31
($ millions)	2026	2025
Restructuring costs	16	1
Earnings of equity-accounted investees	(2)	(5)
Bad debt expense	15	19
Project feasibility costs	18	15
Customer prepayment costs	19	18
Legal expenses	5	5
ARO/ERL related (income) expenses for non-operating sites	(28)	5
Impairment of assets	30	‐
Other expenses	41	10
	114	68

Note 4 Income taxes

	Three Months Ended
	March 31
($ millions, except as otherwise noted)	2026	2025
Actual effective tax rate on earnings (%)	29	49
Actual effective tax rate including discrete items (%)	24	60
Discrete tax adjustments that impacted the tax rate¹	(8)	5
1 Discrete tax adjustments arise from specific, significant or unusual events that are recognized in the period in which the event occurs, rather than being allocated across the year through the annual effective tax rate.

Note 5 Financial instruments

During the three months ended March 31, 2026, we entered into interest rate derivative contracts to manage exposure to changes in variable interest rates on certain long-term debt instruments.

The following table presents the Company's interest rate derivatives outstanding as at March 31, 2026:

	As at March 31, 2026
		Maturities	Average fixed	Fair value of
($ millions, except as otherwise noted)	Notional¹	(year)	interest rate (%)	assets²
Interest rate derivatives - 5-year	250	2026	3.6473	3
Interest rate derivatives - 10-year	350	2026	4.0774	8
1 Notional amounts represent the gross contractual amount outstanding.
2 Fair value of interest rate derivatives are based on a discounted cash flow model using observable market inputs which are classified as Level 2.

Our financial instruments carrying amounts are a reasonable approximation of their fair values, except for our long-term debt, including current portion, that has a carrying value of $9,861 million and fair value of $9,372 million as at March 31, 2026. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

Note 6 Debt

On March 3, 2026, we entered into a $69 million uncommitted revolving demand facility. As at March 31, 2026, there were no borrowings outstanding under this facility.

During the three months ended March 31, 2026, we extended the maturity of our accounts receivable purchase facility from March 6, 2026 to March 31, 2028.

Note 7 Share capital

Share repurchase programs

The following table summarizes our share repurchase activities during the periods indicated below:

	Three Months Ended
	March 31
($ millions, except as otherwise noted)	2026	2025
Number of common shares repurchased for cancellation	2,081,503	2,862,814
Average price per share (US dollars)	70.97	51.08
Total cost, inclusive of tax	148	149

Subsequent to March 31, 2026, as of May 5, 2026, an additional 865,577 common shares were repurchased for cancellation at a cost of $66 million and an average price per share of $73.71.

Dividends declared

We declared a dividend per share of $0.55 (2025 – $0.545) during the three months ended March 31, 2026, payable on April 16, 2026 to shareholders of record on March 31, 2026.

Note 8 Related party transactions

We sell potash outside Canada and the US exclusively through Canpotex. Our total revenue is recognized, at the time product is loaded for shipping, at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. The receivable outstanding from Canpotex arose from sale transactions described above. It is unsecured and bears no interest. Any credit losses held against this receivable are expected to be negligible. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed-upon prices. Purchases from Canpotex for the three months ended March 31, 2026 were $64 million (2025 – $57 million).

	As at	As at
($ millions)	March 31, 2026	December 31, 2025
Receivables from Canpotex	293	279
Payables to Canpotex	74	63

Note 9 Accounting policies, estimates and judgments

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, were adopted effective January 1, 2026, the required adoption date. The amendments clarified the timing of recognition and derecognition of financial assets and financial liabilities. The adoption resulted in a change in the accounting policy relating to the timing of the derecognition of certain financial assets and financial liabilities, such that derecognition now occurs upon settlement.

The amendments were applied retrospectively without restatement of prior periods in accordance with the transitional provisions other than, on initial adoption, there was an adjustment of $(13) million to opening cash and cash equivalents as at January 1, 2026, which has been reflected in the condensed consolidated statement of cash flows for the three months ended March 31, 2026.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260428899674/en/

For Further Information:

Investor Contact:

Jeff Holzman

Senior Vice President, Investor Relations and FP&A

(306) 933-8545 – investors@nutrien.com

Media Contact:

Simon Scott

Vice President, Global Communications

(403) 225-7213 – media@nutrien.com

Nutrien Reports First Quarter 2026 Results